Jessica Robinson-Papp Selected Research

Disease Progression

2/2022	Structural and functional connections between the autonomic nervous system, hypothalamic-pituitary-adrenal axis, and the immune system: a context and time dependent stress response network.
1/2018	Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica Robinson-Papp Research Topics

Disease

10	Pain (Aches) 04/2024 - 09/2015
10	Chronic Pain 01/2022 - 10/2012
4	Mental Disorders (Mental Disorder) 01/2023 - 10/2012
4	Neuralgia (Stump Neuralgia) 01/2022 - 09/2007
4	Polyneuropathies (Polyneuropathy) 01/2022 - 08/2009
3	HIV Infections (HIV Infection) 01/2022 - 08/2009
3	Cognitive Dysfunction 01/2022 - 08/2008
3	Inflammation (Inflammations) 08/2020 - 01/2018
2	Mood Disorders (Mood Disorder) 01/2023 - 01/2022
2	Gliosis 01/2023 - 01/2023
2	Disease Progression 02/2022 - 01/2018
2	Hypertension (High Blood Pressure) 01/2022 - 04/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2017 - 08/2009
1	Peripheral Nerve Injuries 01/2023
1	Psychotic Disorders (Schizoaffective Disorder) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Dysbiosis 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Fever (Fevers) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Infections 10/2020
1	COVID-19 10/2020
1	Spinal Cord Diseases 02/2018
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2013
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 12/2013
1	Leukoencephalopathies 09/2013
1	Central Nervous System Diseases (CNS Diseases) 04/2013
1	Substance-Related Disorders (Drug Abuse) 10/2012
1	Dementia (Dementias) 08/2008
1	Neurologic Manifestations (Neurological Manifestations) 08/2008

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 04/2024 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2020
2	methylglyoxal bis(3-aminopropylamidinohydrazone)IBA 01/2023 - 01/2022
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023 - 08/2020
2	6-chloropenicillanic acid S-sulfoxideIBA 01/2022 - 04/2013
2	Analgesics (Analgesic Drugs)IBA 09/2015 - 09/2013
1	CreatineIBA 01/2023
1	Choline (Choline Chloride)IBA 01/2023
1	CytokinesIBA 01/2023
1	Inositol (Myoinositol)IBA 01/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2022
1	C-Reactive ProteinIBA 01/2022
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	Lipopolysaccharide ReceptorsIBA 01/2019
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2018
1	OligonucleotidesIBA 11/2017
1	Capsaicin (Zostrix)FDA Link 01/2017
1	Diflunisal (Dolobid)FDA Link 12/2013
1	Amyloid (Amyloid Fibrils)IBA 12/2013
1	Prealbumin (Transthyretin)IBA 12/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2013
1	Antidepressive Agents (Antidepressants)IBA 09/2013
1	4-dichlorobenzene (1,4-dichlorobenzene)IBA 09/2013
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 04/2013
1	Cholinergic Antagonists (Anticholinergics)IBA 04/2013
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 09/2007
1	Pregabalin (Lyrica)FDA Link 09/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 04/2017
5	Pain Management 01/2022 - 09/2015
4	Highly Active Antiretroviral Therapy (HAART) 04/2015 - 08/2008
1	Inappropriate Prescribing 01/2022
1	Molecular Targeted Therapy 01/2022
1	Activities of Daily Living (ADL) 01/2016